DaVita Inc
DVA140.830USD
-8.390-5.62%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
9.65BMarktkapitalisierung
14.00KGV TTM
mehr Informationen über DaVita Inc Unternehmen
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
DaVita Inc Informationen
BörsenkürzelDVA
Name des UnternehmensDaVita Inc
IPO-datumOct 31, 1995
CEORodriguez (Javier J)
Anzahl der mitarbeiter76000
WertpapierartOrdinary Share
GeschäftsjahresendeOct 31
Addresse2000 16th St
StadtDENVER
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl80202-5117
Telefon13105362668
Websitehttps://www.davita.com/
BörsenkürzelDVA
IPO-datumOct 31, 1995
CEORodriguez (Javier J)
Führungskräfte von DaVita Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
832.67K
-5165.00%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8191.00%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+7388.00%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.36K
+411.00%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+3834.00%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.54K
+260.00%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
13.98K
+411.00%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
13.44K
+411.00%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
13.08K
-7501.00%
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Independent Director
7.23K
+411.00%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
832.67K
-5165.00%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8191.00%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+7388.00%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.36K
+411.00%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+3834.00%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.54K
+260.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Patient service - Medicare and Medicare Advantage
1.72B
50.15%
Patient service - Commercial
1.06B
30.86%
Patient service - Other government
324.62M
9.49%
Patient service - Medicaid and Managed Medicaid
214.66M
6.28%
Other - Medicare and Medicare Advantage
85.88M
2.51%
Andere
24.33M
0.71%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Patient service - Medicare and Medicare Advantage
1.72B
50.15%
Patient service - Commercial
1.06B
30.86%
Patient service - Other government
324.62M
9.49%
Patient service - Medicaid and Managed Medicaid
214.66M
6.28%
Other - Medicare and Medicare Advantage
85.88M
2.51%
Andere
24.33M
0.71%
Aktionärsstatistik
Aktualisiert: Tue, Feb 3
Aktualisiert: Tue, Feb 3
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Berkshire Hathaway Inc.
43.91%
The Vanguard Group, Inc.
6.05%
BlackRock Institutional Trust Company, N.A.
3.50%
Weschler (R Ted)
3.18%
State Street Investment Management (US)
2.68%
Andere
40.69%
Aktionäre
Aktionäre
Anteil
Berkshire Hathaway Inc.
43.91%
The Vanguard Group, Inc.
6.05%
BlackRock Institutional Trust Company, N.A.
3.50%
Weschler (R Ted)
3.18%
State Street Investment Management (US)
2.68%
Andere
40.69%
Aktionärstypen
Aktionäre
Anteil
Holding Company
43.91%
Investment Advisor
25.88%
Investment Advisor/Hedge Fund
14.22%
Hedge Fund
5.64%
Individual Investor
5.21%
Research Firm
2.49%
Pension Fund
1.87%
Bank and Trust
0.64%
Sovereign Wealth Fund
0.36%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
1268
36.29M
57.41%
+15.99K
2025Q3
1299
36.28M
57.59%
-1.47M
2025Q2
1288
37.75M
54.27%
+725.11K
2025Q1
1275
37.24M
54.43%
-4.83M
2024Q4
1234
39.31M
53.45%
-1.10M
2024Q3
1192
40.91M
54.63%
-1.68M
2024Q2
1162
42.62M
55.55%
-1.85M
2024Q1
1146
44.41M
55.70%
-4.44M
2023Q4
1143
45.66M
55.03%
+259.36K
2023Q3
1139
46.32M
54.25%
+1.22M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Berkshire Hathaway Inc.
31.76M
44.98%
-401.51K
-1.25%
Oct 27, 2025
The Vanguard Group, Inc.
4.21M
5.96%
-518.53K
-10.97%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.40M
3.39%
-242.29K
-9.18%
Sep 30, 2025
Weschler (R Ted)
2.18M
3.09%
--
--
Aug 06, 2024
State Street Investment Management (US)
1.83M
2.6%
-258.50K
-12.35%
Sep 30, 2025
Invesco Capital Management LLC
1.40M
1.98%
+57.02K
+4.25%
Sep 30, 2025
Gates Capital Management, Inc.
1.19M
1.69%
+91.40K
+8.32%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.09M
1.54%
+88.06K
+8.83%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.02M
1.45%
-86.31K
-7.78%
Sep 30, 2025
LSV Asset Management
927.03K
1.31%
-13.70K
-1.46%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Aztlan Global Stock Selection DM SMID ETF
2.59%
State Street SPDR S&P Health Care Services ETF
1.84%
Strategas Global Policy Opportunities ETF
1.64%
Invesco S&P 500 Equal Weight Health Care ETF
1.47%
Pacer US Cash Cows Growth ETF
1.02%
AdvisorShares Insider Advantage ETF
0.95%
Global X Aging Population ETF
0.75%
iShares U.S. Healthcare Providers ETF
0.67%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.67%
LeaderShares AlphaFactor US Core ETF
0.66%
Mehr Anzeigen
Aztlan Global Stock Selection DM SMID ETF
Anteil2.59%
State Street SPDR S&P Health Care Services ETF
Anteil1.84%
Strategas Global Policy Opportunities ETF
Anteil1.64%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.47%
Pacer US Cash Cows Growth ETF
Anteil1.02%
AdvisorShares Insider Advantage ETF
Anteil0.95%
Global X Aging Population ETF
Anteil0.75%
iShares U.S. Healthcare Providers ETF
Anteil0.67%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Anteil0.67%
LeaderShares AlphaFactor US Core ETF
Anteil0.66%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
